Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer
Abstract
Colon cancer is one of the most common cancers in the developed countries. The association between transforming growth factor TGFα and human cancer incidence has been suggested, yet, the regulatory roles of TGFα and the molecular mechanisms remain unknown, especially in colon cancer. We aim to investigate the functional regulations of TGFα in colon cancer progression. Two colon cancer cell lines were applied, and plasmid overexpression and siRNA-mediated depletion techniques were used to verify the role of TGFα in colon cancer. Cell proliferation was analyzed by MTS assay and colony formation assay, and western blot assay was used to examine protein expression. Migration, invasion, and reporter assays were also carried out to study the regulations of TGFα in colon cancer. Our results evidenced that expression of TGFα facilitates short-term and long-term proliferations of colon cancer cells. Moreover, TGFα was suggested as a migration-and-invasion promoting factor of colon cancer. Finally, our data indicated that TGFα modulates epithelial-mesenchymal transition (EMT) markers and NFκB signaling pathway in colon cancer cells. We provide the first time evidence of the promoting role TGFα plays in colon cancer tumorigenesis with proposed regulatory mechanisms involving EMT alteration and NFκB signaling pathway.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Multiplex cytokine assay shows a significant increase in VEGF and TGFɑ and other factors implicated in EMT in PLX-resistant versus parental cells.
“Multiplex cytokine assay shows a significant increase in the level of VEGF, which is known to promote EMT, invasion, and angiogenesis [8], as well as an increase in TGFɑ, a proliferation and invasion promoting factor in CRC [25] and other factors implicated in EMT (Fig. 2 F; Supp. Fig. 2).”
From Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer (2026) · cites this paper as [25]
Cited by
Sorted by citations
Single-cell transcriptomics of human-skin-equivalent organoids
Stabell, A. R., Lee, G. E., Jia, Y., Wong, K. N., Wang, S., Ling, J., Nguyen, S. D., Sen, G. L., Nie, Q., & Atwood, S. X. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112511 · Cited by 30 · see citing works
Geisen, M. E., Tessmann, J. W., Kelson, C. O., He, D., Wang, C., Faisal, A. S. M., Beswick, E. J., Baca, Y., Rock, S., Kolesar, J. M., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101283
“Multiplex cytokine assay shows a significant increase in the level of VEGF, which is known to promote EMT, invasion, and angiogenesis [8], as well as an increase in TGF ɑ , a proliferation and invasion promoting factor in CRC [25] and other factors implicated in EMT (Fig.”
- Authors
- Yu, C.-Y., Chang, W.-C., Zheng, J.-H., Hung, W.-H., & Cho, E.-C.
- Affiliations
- Taipei Medical University (TW)
- Corresponding author
- Cho, Er-Chieh
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 506
- Issue
- 4
- Pages
- 901-906
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2898856933
- Cited by
- 19
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 3
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology, Taiwan (MOST 106-2320-B-038-009, MOST 107-2320-B-038-054)
- Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-114020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- transforming growth factor-alpha, colon cancer, carcinogenesis, epithelial-mesenchymal transition, cell proliferation, cell migration, cell invasion, NF-κB signaling, tumor progression
- MeSH terms
- Cell Movement, Colonic Neoplasms, Humans, Neoplasm Invasiveness, Transforming Growth Factor alpha, NF-kappa B, Disease Progression, Cell Line, Tumor, Cell Proliferation, Epithelial-Mesenchymal Transition, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review